GT201200066A - Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen - Google Patents
Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienenInfo
- Publication number
- GT201200066A GT201200066A GT201200066A GT201200066A GT201200066A GT 201200066 A GT201200066 A GT 201200066A GT 201200066 A GT201200066 A GT 201200066A GT 201200066 A GT201200066 A GT 201200066A GT 201200066 A GT201200066 A GT 201200066A
- Authority
- GT
- Guatemala
- Prior art keywords
- oxazolobenzodiazepinonas
- dihidro
- derivatives
- new
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A NUEVOS DERIVADOS DIHIDRO-OXAZOLOBENZODIAZEPINONAS, SU PROCEDIMIENTO DE PREPARACIÓN Y LAS COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1100682A FR2972454B1 (fr) | 2011-03-08 | 2011-03-08 | Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT201200066A true GT201200066A (es) | 2013-10-10 |
Family
ID=44004482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT201200066A GT201200066A (es) | 2011-03-08 | 2012-03-08 | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen |
Country Status (44)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU230684B1 (hu) * | 2014-01-21 | 2017-08-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Új dihidro-oxazino-benzodiazepin vegyületek és eljárás ezek elõállítására, illetve az ezeket tartalmazó gyógyászati készítmények |
| DE102016005291B4 (de) | 2016-04-29 | 2024-01-11 | Ksg Austria Gmbh | Verfahren zur Herstellung eines elektronischen Gerätes in der Form eines Spritzgußteils mit eingelegter Leiterplatte |
| CN115304620A (zh) * | 2021-05-07 | 2022-11-08 | 上海赛默罗生物科技有限公司 | 嘧啶酮衍生物、其制备方法、药物组合物和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0101223B1 (en) | 1982-08-06 | 1987-04-01 | Ube Industries, Ltd. | process for producing phenylacetones |
| US5891871A (en) * | 1996-03-21 | 1999-04-06 | Cocensys, Inc. | Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| UA67749C2 (uk) * | 1997-08-12 | 2004-07-15 | Егіш Дьйодьсердьяр Рт. | Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування |
| EP1015457B1 (en) * | 1997-08-12 | 2003-11-26 | Egis Gyogyszergyar Rt. | 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors |
| GB9900222D0 (en) * | 1999-01-06 | 1999-02-24 | Merck Sharp & Dohme | Therapeutic compounds |
| HU227128B1 (en) * | 1999-07-07 | 2010-07-28 | Egyt Gyogyszervegyeszeti Gyar | New 2,3-benzodiazepine derivatives |
| EP1951050A4 (en) * | 2005-10-26 | 2011-04-27 | Univ Michigan | THERAPEUTIC COMPOSITIONS AND METHOD |
| HU230760B1 (hu) * | 2005-12-30 | 2018-03-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Dihidro-2,3-benzodiazepin-származékok optikai izomerjei, eljárás ezek sztereoszelektív szintézisére, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények és az eljárás közbenső termékei |
| EP2298296A1 (en) * | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
-
2011
- 2011-03-08 FR FR1100682A patent/FR2972454B1/fr active Active
-
2012
- 2012-02-20 IL IL218215A patent/IL218215A/en active IP Right Grant
- 2012-02-21 JO JO201236A patent/JO2948B1/en active
- 2012-02-22 SG SG2012012340A patent/SG184633A1/en unknown
- 2012-02-22 PE PE2012000242A patent/PE20121682A1/es active IP Right Grant
- 2012-02-22 AU AU2012201031A patent/AU2012201031B2/en not_active Ceased
- 2012-02-22 PH PH1/2012/000035A patent/PH12012000035A1/en unknown
- 2012-02-24 MY MYPI2012700036A patent/MY162537A/en unknown
- 2012-02-27 CL CL2012000496A patent/CL2012000496A1/es unknown
- 2012-02-28 UY UY0001033927A patent/UY33927A/es unknown
- 2012-03-02 MA MA34658A patent/MA33641B1/fr unknown
- 2012-03-05 GE GEAP201212613A patent/GEP20146017B/en unknown
- 2012-03-05 CA CA2771189A patent/CA2771189C/fr not_active Expired - Fee Related
- 2012-03-06 EC ECSP12011711 patent/ECSP12011711A/es unknown
- 2012-03-06 CR CR20120109A patent/CR20120109A/es unknown
- 2012-03-06 AP AP2012006149A patent/AP3344A/xx active
- 2012-03-06 MX MX2012002788A patent/MX2012002788A/es active IP Right Grant
- 2012-03-07 BR BRBR102012005137-0A patent/BR102012005137A2/pt not_active Application Discontinuation
- 2012-03-07 UA UAA201202760A patent/UA112153C2/uk unknown
- 2012-03-07 ES ES12290077.2T patent/ES2442293T3/es active Active
- 2012-03-07 NZ NZ598625A patent/NZ598625A/xx not_active IP Right Cessation
- 2012-03-07 HN HN2012000485A patent/HN2012000485A/es unknown
- 2012-03-07 RS RS20130492A patent/RS53032B/sr unknown
- 2012-03-07 SA SA112330331A patent/SA112330331B1/ar unknown
- 2012-03-07 PL PL12290077T patent/PL2497774T3/pl unknown
- 2012-03-07 PT PT122900772T patent/PT2497774E/pt unknown
- 2012-03-07 SA SA112330231A patent/SA112330231B1/ar unknown
- 2012-03-07 DK DK12290077.2T patent/DK2497774T3/da active
- 2012-03-07 NI NI201200039A patent/NI201200039A/es unknown
- 2012-03-07 JP JP2012050550A patent/JP5475816B2/ja not_active Expired - Fee Related
- 2012-03-07 US US13/413,977 patent/US8778932B2/en not_active Expired - Fee Related
- 2012-03-07 EA EA201200267A patent/EA021125B1/ru not_active IP Right Cessation
- 2012-03-07 WO PCT/FR2012/000080 patent/WO2012120206A1/fr not_active Ceased
- 2012-03-07 AR ARP120100728A patent/AR085691A1/es unknown
- 2012-03-07 RU RU2013144824/04A patent/RU2572556C2/ru not_active IP Right Cessation
- 2012-03-07 EP EP12290077.2A patent/EP2497774B1/fr active Active
- 2012-03-07 TW TW101107763A patent/TWI428342B/zh not_active IP Right Cessation
- 2012-03-07 ZA ZA2012/01681A patent/ZA201201681B/en unknown
- 2012-03-07 SI SI201230017T patent/SI2497774T1/sl unknown
- 2012-03-08 KR KR1020120023935A patent/KR101477991B1/ko not_active Expired - Fee Related
- 2012-03-08 CU CUP2012000041A patent/CU24134B1/es unknown
- 2012-03-08 CN CN201210063418.8A patent/CN102675341B/zh not_active Expired - Fee Related
- 2012-03-08 GT GT201200066A patent/GT201200066A/es unknown
-
2013
- 2013-12-13 CY CY20131101128T patent/CY1114729T1/el unknown
-
2014
- 2014-01-16 HR HRP20140050AT patent/HRP20140050T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201400142A (es) | Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| GT201400144A (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| GT201000023A (es) | Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met. | |
| CU20140095A7 (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| DOP2013000307A (es) | Antagonistas de trpv4 | |
| CR20140106A (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
| CO7210068A1 (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| CU20170160A7 (es) | Derivadosde fenil-tieno(2,3-d)pirimidina- hidroxi-ésteres, un proceso para su preparación y composiciones farmacéuticas que lo contienen | |
| UY35467A (es) | Compuestos orgánicos | |
| PT2773748T (pt) | Neurónios dopaminérgicos (da) do mesencéfalo para enxerto | |
| ECSP13013074A (es) | Nuevos derivados de piridina | |
| UY34698A (es) | Combinaciones farmacéuticas que comprenden un análogo de tionucleótidos | |
| UY34602A (es) | ?Derivados de bencimidazolil- e imidazopiridinil-metilamina? | |
| MX338078B (es) | Cristales de anticuerpos anti-esclerostina y formulaciones de los mismos. | |
| CR20140275A (es) | Triazolopiridinas sustituidas | |
| UY34779A (es) | Anticuerpos anti-il-23 y composiciones farmacéuticas que los contienen | |
| CR20150250A (es) | Nuevos derivados de piridina | |
| HN2010001537A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CR20150204A (es) | Nuevos derivados de piridina | |
| MX2017007377A (es) | Compuestos organicos. | |
| MX340983B (es) | Composiciones farmaceuticas y nutraceuticas de acido abscisico. | |
| EP2815752A4 (en) | ORAL PHARMACEUTICAL COMPOSITION | |
| MX347855B (es) | Derivados de anilina, su preparación y su aplicación terapéutica. | |
| CO6960548A2 (es) | Polimorfos de arry-380, un inhibidor selectivo de herb2 y composiciones farmacéuticas que los contienen | |
| EP2815753A4 (en) | ORAL PHARMACEUTICAL COMPOSITION |